- Report
- May 2023
- 80 Pages
India
From €1322EUR$1,500USD£1,162GBP
- Report
- May 2023
- 80 Pages
Germany
From €1322EUR$1,500USD£1,162GBP
- Report
- May 2023
- 80 Pages
France
From €1322EUR$1,500USD£1,162GBP
- Report
- May 2023
- 100 Pages
Africa
From €1763EUR$2,000USD£1,549GBP
- Report
- May 2023
- 255 Pages
Global
From €1102EUR$1,250USD£968GBP
€2204EUR$2,500USD£1,936GBP
- Newsletter
- December 2025
- 2 Pages
Global
From €115EUR$131USD£101GBP
- Report
- October 2025
- 87 Pages
Kuwait
From €4276EUR$4,850USD£3,756GBP
- Report
- October 2025
- 89 Pages
Qatar
From €4276EUR$4,850USD£3,756GBP
- Report
- October 2025
- 25 Pages
Italy
From €995EUR$1,209USD£905GBP
- Report
- October 2025
- 25 Pages
France
From €995EUR$1,209USD£905GBP
- Report
- October 2025
- 24 Pages
Saudi Arabia
From €995EUR$1,209USD£905GBP
- Report
- October 2025
- 26 Pages
Taiwan
From €995EUR$1,209USD£905GBP
From €995EUR$1,209USD£905GBP
- Report
- September 2025
- 26 Pages
Canada
From €995EUR$1,209USD£905GBP
- Report
- September 2025
- 25 Pages
Germany
From €995EUR$1,209USD£905GBP
- Report
- September 2025
- 25 Pages
United Kingdom
From €995EUR$1,209USD£905GBP
- Report
- September 2025
- 23 Pages
China
From €995EUR$1,209USD£905GBP
- Report
- September 2025
- 30 Pages
Australia
From €995EUR$1,209USD£905GBP
- Report
- August 2025
- 73 Pages
From €3042EUR$3,450USD£2,671GBP
- Report
- April 2025
- 100 Pages
China
From €1587EUR$1,800USD£1,394GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more